Medicines for Maternal Health
Key Data and Findings
Expanding access to quality, affordable maternal health medicines is critical to making progress in reducing maternal mortality. However, significant challenges often impede such access. Chief among them is a lack of data on the needs, gaps, systems and financing for maternal health medicines.
This report, prepared for the United Nations Commission on Commodities for Women and Children’s Health, provides a review of the current conditions and available evidence on maternal health medicines, specifically Oxytocin and Misoprostol to prevent post-partum haemorrhage and magnesium sulfate, considered the safest, most effective, and lowest-cost medication for treating pre-eclampsia and eclampsia.
The report also includes 11 priority issues for actions
Under the auspices of the United Nations Secretary-General’s Every Woman Every Child initiative, the Commission on Life-Saving Commodities for Women and Children advocates at the highest levels for the increased availability, affordability and accessibility of essential but underutilized commodities for maternal and child health.
Author: UNFPA No. of pages: 37 Publication date: 2012 Available languages: English
About Team Celebration
Team Celebration is a devoted group of women dedicated to sharing information that will better the lives of all women making this space a truly convenient Resource for Women globally. Speak Your Mind: You are invited to leave comments and questions below.
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
You simply type a KEY WORD into our SEARCH BOX at TOP RIGHT of Homepage and a list of associated topic articles offering truly educational and informative features will be at your fingertips.
Medicines for Maternal Health, Key Data and Findings
March 25, 2012 by
